Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice
- PMID: 219129
- PMCID: PMC2184834
- DOI: 10.1084/jem.149.3.774
Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice
Abstract
When cyclophosphamide was administered to mice before immunization with syngeneic SV40 transformed cells, the specific immune response elicited, as was measured by in vitro 51Cr release assay was stronger and lasted longer when compared to the response generated in noncyclophosphamide-treated mice. The augmentation effect of the drug was dependent on cyclophosphamide concentration being optimal at 100 mg/kg and on the time of drug administration in relation to antigen immunization being optimal at 2 d before antigen administration. Transfer of T cells from normal syngeneic mice to drug-treated animals abolished the cyclophosphamide-induced augmentation of immune response. These results implied that cyclophosphamide sensitive T cells suppressed the in vivo generation of specific effector T cells against SV40-induced tumor-associated antigens.
Similar articles
-
Augmentation of specific immune response against a syngeneic SV40-induced sarcoma in mice by depletion of suppressor T cells with cyclophosphamide.Cell Immunol. 1979 Dec;48(2):339-45. doi: 10.1016/0008-8749(79)90128-x. Cell Immunol. 1979. PMID: 228870 No abstract available.
-
Generation of cytotoxic lymphocytes by SV40-induced antigens.J Immunol. 1982 May;128(5):2160-3. J Immunol. 1982. PMID: 6278025
-
Specific immune response against tumor-associated antigens of a syngeneic simian virus 40-induced sarcoma in mice.J Natl Cancer Inst. 1978 Nov;61(5):1351-5. doi: 10.1093/jnci/61.5.1351. J Natl Cancer Inst. 1978. PMID: 213615 No abstract available.
-
Immunopathology of polyoma-induced tumors.Springer Semin Immunopathol. 1982;4(4):317-32. doi: 10.1007/BF02053738. Springer Semin Immunopathol. 1982. PMID: 6293109 Review. No abstract available.
-
Differential antigen presentation in tumor immunity.Fed Proc. 1984 Jun;43(9):2460-4. Fed Proc. 1984. PMID: 6327399 Review.
Cited by
-
Eradication of a large MOPC-315 tumor in athymic nude mice by chemoimmunotherapy with Lyt2+ splenic T cells from melphalan-treated BALB/c mice bearing a large MOPC-315 tumor.Cancer Immunol Immunother. 1990;31(3):129-38. doi: 10.1007/BF01744726. Cancer Immunol Immunother. 1990. PMID: 2337902 Free PMC article.
-
Inverse relationship between anti-SV40 TASA and anti-H-2 cytotoxic responses.J Cancer Res Clin Oncol. 1983;106(2):117-22. doi: 10.1007/BF00395389. J Cancer Res Clin Oncol. 1983. PMID: 6313694 Free PMC article.
-
Enhancement of delayed hypersensitivity reaction with varieties of anti-cancer drugs. A common biological phenomenon.J Exp Med. 1981 Jul 1;154(1):204-9. doi: 10.1084/jem.154.1.204. J Exp Med. 1981. PMID: 6788892 Free PMC article.
-
Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy.Cancer Immunol Immunother. 2009 Mar;58(3):317-24. doi: 10.1007/s00262-008-0576-4. Epub 2008 Aug 15. Cancer Immunol Immunother. 2009. PMID: 18704409 Free PMC article. Review.
-
Resistance of simian virus 40-transformed hamster cells to the cytolytic effect of activated macrophages: a possible factor in species-specific viral oncogenicity.Proc Natl Acad Sci U S A. 1980 Nov;77(11):6773-7. doi: 10.1073/pnas.77.11.6773. Proc Natl Acad Sci U S A. 1980. PMID: 6256760 Free PMC article.